HMSA Provider Update Healthpro News
HealthPro News A monthly publication for participating HMSA health care providers, facilities, and their staff. October 2016
ADMINISTRATION & NEWS
C Q M Open Enrollment Season Open enrollment is here! HMSA has resources to help your patients learn more about the open enrollment What’s season. These resources include posters to display in your office and rack cards to Inside give your patients or have available at your reception counter. The open enrollment periods for our members include: Coding & Claims • QUEST Integration: October 1–31. 4 • EUTF retirees: October 10–31. Pharmacy • HMSA Akamai Advantage®: October 15–December 7. 4 • Affordable Care Act (ACA), individuals and small groups: November 1–January 31. Plans 11 • Federal Plan 87: November 14–December 12. To get these open enrollment resources, email Provider Services at Policy News [email protected] or call 948-6820 on Oahu or 1 (877) 304-4672 11 toll-free on the Neighbor Islands.
Calendar 13 C Q M Bone Density Scans HMSA is offering a new service for HMSA Akamai Advantage members who need evaluation for osteoporosis. Members who have had a recent fracture and have difficulty going to an imaging center for a DXA scan can have a heel scan provided by our Health Management staff at an HMSA Center or in their home. HMSA will contact physicians to offer this service as we identify members who are eligible. Heel scans are free for eligible members; HMSA will handle scheduling and testing and will send the results to your office. C Q M Commercial QUEST Medicare C Q M Integration 2016 High Performer Program HMSA is pleased to offer a special bonus program to our primary care providers again this year. This program identifies members who may be less likely to receive certain preventive services and rewards providers for their extra effort to encourage these patients to take an active role in their health care.
Hawai‘i Medical 818 Keeaumoku St. P.O. Box 860 hmsa.com Provider Resource Center Service Association (808) 948-6330 Honolulu, HI 96808-0860 hhin.hmsa.com hmsa.com/portal/provider
An Independent Licensee of the Blue Cross and Blue Shield Association 1100-6351 2 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
ADMINISTRATION & NEWS (CONTINUED)
This is an invitation-only program for PCPs who meet performance and volume criteria. Providers will receive bonus payments for each gap they close for their targeted patients.
We’re also pleased to once again offer incentives for your entire team. We know that your staff plays an essential role in the success of this program, so they’re eligible for gift cards when they achieve certain goals.
Invitation letters and detailed program guides were mailed to providers on September 1. The program runs through December 31, 2016. To find out how to participate or if you have any questions, please call us at 952-7822 on Oahu.
C Q M Telephone Survey to Assess Appointment Availability SPH Analytics will call you this month about the availability of the following types of appointments for HMSA QUEST Integration members: • Urgent care visits (high fever, ear pain, or infections): within 24 hours. • PCP pediatric sick visits: within 24 hours. • PCP adult sick visits: within 72 hours. • Behavioral health visits (routine visits for adults and children): within 21 days. • PCP visits (routine visits for adults and children): within 21 days. • Specialist visits: within four weeks. • Non-emergency hospital stays: within four weeks. Our goal is 90 percent or better for appointment availability.
The survey takes less than 10 minutes to complete. If another time would be more convenient than when we call, let us know and we’ll call you back at a time that works for you. Thank you in advance for taking the time from your busy schedule to respond to this telephone survey. The information you provide to SPH Analytics helps us maintain our successful relationship with the state of Hawaii for our QUEST Integration plan. Here are the results from the previous survey.
SHHMSA QUEST Integration Appointment Availability Report Second quarter 2016
% of requests that meet Average wait (days) Provider Type/Class Wait standard waiting time for those over standard standard
Urgent care 24 hours 97.4% 6 days
PCP pediatric sick visits 24 hours 97.6% 20 days
PCP adult sick visits 72 hours 99.1% 21.5 days
Behavioral health (routine visits for adults and children) 21 days 92.9% 35 days
PCP visits (routine visits for adults and children) 21 days 99.4% 54 days
Specialist 4 weeks 97.1% 59 days
Non-emergent hospital stays 4 weeks 99.4% 24 days
C Q M Commercial QUEST Medicare Integration 3 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
ADMINISTRATION & NEWS (CONTINUED)
C Q M Behavioral Health: Telephone Survey on Appointment Availability We’d like to ensure that our members have good access to behavioral health providers when they need care. As part of our quality improvement efforts, we’ve contracted with SPH Analytics to conduct a behavioral health-specific survey this month. If SPH Analytics calls your office, we kindly ask that you participate in the short telephone survey. Your ability to confirm that our members have good access to behavioral health services is greatly appreciated. Good access to behavioral health providers is generally defined as a patient receiving care for: • Non-life-threatening emergencies within six hours. • Urgent care appointments within 48 hours. • Initial routine care appointments within 10 business days. • Follow-up routine care appointments within 10 business days. • Follow-up appointment within seven calendar days after a hospital discharge. HMSA is fortunate to have an excellent provider network and anticipate great survey results. We’ll report the results in future issues of HealthPro News. Thank you in advance for taking the time to participate in this important survey.
C Q M Payment Transformation 835 Electronic Remittance We’re modifying the way check, claim, and service line level adjustments appear on our Report-to-Provider statements and Electronic Remittance Advice (HIPAA 835 transaction). These changes will more accurately reflect reimbursement under the HMSA payment transformation model. They’ll provide a greater amount of detail and should help providers in the payment transformation program reconcile payment for claims. We’re hoping to make the changes in the first quarter of next year. We’ll provide more details soon. If you have questions, please contact your Provider Services field representative or call 948-6820 on Oahu or 1 (877) 304-4672 toll-free on the Neighbor Islands.
C Q M Clinical Labs of Hawaii Clinical Labs of Hawaii offers physicians the ability to view their patients’ results online anytime with its Physician Portal at md.clinicallabs.com. This mobile-friendly application provides lab and pathology results to physicians and their staff in real time. Key features of CLH’s online Physician Portal include: • Alternate medical record number search capability. For lab reports, search for the test name, report type, collection date, patient name, date of birth, CLH medical record number (MRN), or client-generated IDs. • Viewable PDF reports. Physicians may download the lab reports, file them as attachments in their local electronic medical records (EMR) systems, or print the reports and file a hard copy with the patient’s medical record. • Cumulative lab reports. Cumulative lab reports enable users to view comparative test results over a specified period of time and create and save multiple cumulative report templates. The Physician Portal ensures the confidentiality of patient data in accordance with standards outlined in HIPAA regulations. For information about the Physician Portal, please email a service representative at [email protected] or call 677-7998 on Oahu.
C Q M Commercial QUEST Medicare Integration 4 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
CODING & CLAIMS
C Q M Claims Processing Change for Bundled Codes For claims processed on or after January 1, 2017, HMSA will no longer separately pay for 92133 and 92134 when these two codes are billed together for the same date of service and rendered by the same provider. Procedures 92133 and 92134 aren’t considered distinct procedures. CPT manual guidelines say, “Do not report 92133 and 92134 at the same patient encounter.” Therefore, the following modifiers aren’t appropriate to bill with these codes: 58, 59, 78, 79, XE, XS, XP, or XU. This is consistent with CMS NCCI bundling editing. Affected codes: • 92133 — Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; optic nerve. • 92134 — Scanning computerized ophthalmic diagnostic imaging, posterior segment, with interpretation and report, unilateral or bilateral; retina.
PHARMACY
C Q M Insulin Changes Thank you for taking the time to provide feedback on our preferred insulin changes. We’ve taken your feedback into consideration and will be working with our prior authorization center to streamline the process for your patients who must remain on their current regimen. Effective December 1, 2016, Novolin® (with the exception of ReliOn® Novolin), NovoLog®, and Lantus® will be the preferred brands of insulin on the Select, Choice, Essential, and Metallic formularies. Current therapies will have a transition period until February 28, 2017, to switch to a preferred product. We encourage you to help your patients switch as soon as possible. If you believe that your patient should continue taking their current medication, you can request a non-formulary exception on the Essential Prescription formulary or submit a medical necessity prior authorization (MN-PA) on the Select, Choice, or Metallic formularies. These requests can be submitted after December 1. Call HMSA’s pharmacy benefits manager, CVS Caremark®, at 1 (855) 240-0543 toll-free to initiate a coverage review, which can be completed by phone or fax. You may also go online to www2.caremark.com/epa. If the exception is approved, the member copayment will vary dependent on the member’s drug plan. We’re aware that Levemir® is in pregnancy category B. If you request prior authorization for treatment of gestational diabetes, we’ll pay for the medication.
CVS Caremark® is an independent company providing pharmacy benefit management services on behalf of HMSA.
C Q M Commercial QUEST Medicare Integration 5 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
PHARMACY (CONTINUED)
Essential Formulary
Non-formulary Medications Alternative Covered Medications
Afrezza® (inhaled regular insulin)
Rapid-acting Apidra® (insulin glulisine) NovoLog products (insulin aspart)
Humalog® products (insulin lispro)
Humulin® products* (regular insulin, insulin NPH) Short- and Novolin products (regular insulin, insulin NPH) intermediate-acting ReliOn Novolin
Basaglar® (insulin glargine) Lantus (insulin glargine) Levemir (insulin detemir) (>200 units of insulin per day, Long-acting/basal consider endocrinology consultation) Toujeo® (insulin glargine)
Tresiba® (insulin degludec)
Humulin Mix (insulin NPH/regular insulin) Novolin Mix (isophane (NPH)/regular)
Humalog Mix (lispro protamine/lispro) NovoLog Mix (aspart protamine/aspart) Mix insulin ReliOn Novolin Mix Novolin Mix (isophane (NPH)/regular)
Ryzodeg® (insulin degludec/insulin aspart) NovoLog (insulin aspart) + Lantus (insulin glargine)
Select, Choice, and Metallic Formularies
Medications Requiring a Alternative Covered Medications Medical Necessity Prior Authorization (MN-PA)
Afrezza (inhaled regular insulin)
Rapid-acting Apidra (insulin glulisine) NovoLog products (insulin aspart)
Humalog products (insulin lispro)
Humulin products* (regular insulin, insulin NPH) Short- and (regular insulin, insulin NPH) Novolin products (regular insulin, insulin NPH intermediate-acting ReliOn Novolin
Basaglar (insulin glargine) Lantus (insulin glargine) - tier 1 Long-acting/basal Levemir (insulin detemir) Toujeo (insulin glargine) - tier 3
Tresiba (insulin degludec)
Humulin Mix (insulin NPH/regular insulin) Novolin Mix (isophane (NPH)/regular)
Humalog Mix (lispro protamine/lispro) NovoLog Mix (aspart protamine/aspart)
Mix insulin ReliOn Novolin Mix Novolin Mix (isophane (NPH)/regular)
NovoLog (insulin aspart) + (insulin glargine) Ryzodeg (insulin degludec/insulin aspart) (Lantus -tier 1 or Toujeo - tier 3)
*Except Humulin R U-500®
C Q M Commercial QUEST Medicare Integration 6 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
PHARMACY (CONTINUED)
C Q M New Antiretroviral Medications for HIV-1 Treatment Newer formulations of existing antiretrovirals (ARVs) for the treatment of HIV-1 provide additional, effective options with the potential for less toxicity, less complicated dosing, and a reduced risk of drug resistance. Tenofovir disoproxil fumarate, also known as TDF, is the principal component of several existing ARV combinations (Stribild®, Atripla®, Complera®, and Truvada®). However, TDF has been associated with bone loss and kidney toxicity with long-term use. Newer product combinations replace TDF with a new formulation of tenofovir, called tenofovir alafenamide (or TAF). TAF is hailed as a “gentler version” of tenofovir because it can be given at a lower dose. Based on preliminary data, TAF products appear to provide “sustained bone (BMD) improvements” and stable kidney function parameters compared with TDF products. Genvoya®, Odefsey®, and Descovy® are the most recent TAF-containing HIV medications that are approved by the FDA for the treatment of naïve HIV-infected adults. Studies have shown that TAF products provide similar efficacy in reducing HIV viral load as their TDF counterparts. Recently, the U.S. Department of Health and Human Services updated its guidelines to include Genvoya as a first-line treatment option for naïve HIV-infected adults. After HMSA’s Pharmacy and Therapeutics Committee has reviewed these medications and with feedback from community infectious disease physicians, HMSA will add these HIV medications as preferred agents on the Select, Choice, Essential, and Metallic formularies as of October 1. This decision was based on the potential for these medications to have a better safety profile.
C Q M Epinephrine Auto-injectors There has been news that the manufacturer of EpiPen® has been consistently increasing the price of this medication. As you’re aware, EpiPens are used for the emergency treatment of life-threatening allergic reactions including anaphylaxis. While the retail price of the EpiPen has increased, the majority of our members aren’t affected by the increase since they’re protected by a set copayment. However, members with a deductible or coinsurance may have to pay more. HMSA covers EpiPens on all our formularies. Currently, there’s no generic for EpiPen, but there’s an FDA-approved generic epinephrine auto-injector that’s available, which is an authorized generic for Adrenaclick and is also covered on all HMSA formularies. Prescriptions need to be written as “generic epinephrine auto-injector” or “generic Adrenaclick” for the pharmacy to dispense the generic epinephrine. Drug companies that increase their prices cause unneeded strain on the capacity of our health care dollars to provide access to needed care.
C Q M Commercial QUEST Medicare Integration 7 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
PHARMACY (CONTINUED)
C Q M Control Formulary Changes The Pharmacy and Therapeutics Committee made the following formulary changes effective January 1, 2017. The Control Formulary can be found in the HMSA Provider Resource Center: hmsa.com/portal/provider/ HMSA_Control_Formulary.pdf.
Utilization Management Generic Name Brand Name Drug Class Current Tier New Tier Description/Notes
carbamazepine XR Tegretol XR Anticonvulsants 2 3 Alternative: carbamazepine XR Ophthalmic/ cyclosporine Restasis 2 Non-formulary Alternative: Xiidra dry eye disease hydrocodone bitartrate Hysingla ER Analgesics 3 2
Unifine PNTP Mis 29G x 12 mm (1/2”), 31G x 8mm insulin pen needle Antidiabetic/supplies Non-formulary 3 (1/3” or 5/16”), 32G x 5mm (3/16”), 31G x 6 mm (1/4”)
Ophthalmic/ lifitegrast Xiidra drops Non-formulary 2 dry eye disease linagliptin/ Antidiabetic/ Jentadueto XR Non-formulary 3 metformin HCl SR DPP-4 inhibitor
naloxone autoinjector Evzio autoinjector Opioid antagonist Non-formulary 2
naloxone HCl nasal Narcan nasal spray Opioid antagonist Non-formulary 2 spray
perampanel suspension Fycompa suspension Anticonvulsants Non-formulary 2
Neprilysin Inhibitor/ sacubitril/valsartan Entresto Angiotensin II Non-formulary 2 receptor agonist
uridine triacetate Vistogard Antidote 3 2
Specialty
Utilization Management Generic Name Brand Name Drug Class Current Tier New Tier Description/Notes
Antiretroviral agents/ dolutegravir sodium Tivicay Non-formulary 4 integrase inhibitors
C Q M Commercial QUEST Medicare Integration 8 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
PHARMACY (CONTINUED)
C Q M Essential Prescription Formulary Changes The Pharmacy and Therapeutics Committee made the following formulary changes effective January 1, 2017. The Essential Prescription Formulary can be found in the HMSA Provider Resource Center: hmsa.com/portal/provider/ HMSA_Essential_Prescription_Formulary.pdf.
Current Utilization Management Generic Name Brand Name Drug Class New Tier Tier Description/Notes
Generic budesonide Corticosteroid 1 Non-formulary Alternative: Rhinocort Allergy OTC Rhinocort Aqua
conjugated estrogens/ Duavee Estrogen combinations 3 2 bazedoxifene
Alternatives: diclofenac, ibuprofen, diclofenac Zorvolex NSAIDs 3 Non-formulary meloxicam, naproxen, indomethacin, capsules or other generic NSAIDs on formulary
Alternatives: diclofenac, ibuprofen, diclofenac meloxicam, naproxen, indomethacin, powder for Cambia NSAIDs 3 Non-formulary other generic NSAIDs on formulary, oral solution or generic serotonin-receptor agonist on formulary
diclofenac Alternatives: diclofenac, ibuprofen, liquid filled Zipsor NSAIDs 3 Non-formulary meloxicam, naproxen, indomethacin, capsules or other generic NSAIDs on formulary
Alternatives: ketorolac (oral), ibuprofen, ketorolac Sprix NSAIDs 3 Non-formulary meloxicam, naproxen, indomethacin, nasal spray or other generic NSAIDs on formulary
Specialty
Utilization Management Generic Name Brand Name Drug Class Current Tier New Tier Description/Notes
obeticholic acid Ocaliva Gastrointestinal agent Non-formulary 5 Prior authorization
pimavanserin Nuplazid Antipsychotic Non-formulary 5 Prior authorization
Prior authorization tobramycin Tobi podhaler Aminoglycoside 3 5 Alternative: tobramycin (generic Tobi)
C Q M Commercial QUEST Medicare Integration 9 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
PHARMACY (CONTINUED)
C Q M Metallic Formulary Changes The Pharmacy and Therapeutics Committee made the following formulary changes effective January 1, 2017.
Utilization Management Generic Name Brand Name Drug Class Current Tier New Tier Description/Notes
Prior authorization: covered for pregnant Generic females only budesonide Corticosteroid 1 1 Rhinocort Aqua Alternatives: fluticasone, flunisolide, and OTC alternatives conjugated estrogens/ Duavee Estrogen combinations 3 2 bazedoxifene ketorolac nasal spray Sprix NSAIDs 3 3 Prior authorization
Specialty
Utilization Management Generic Name Brand Name Drug Class Current Tier New Tier Description/Notes
obeticholic acid Ocaliva Gastrointestinal agent Non-formulary 5 Prior authorization
pimavanserin Nuplazid Antipsychotic Non-formulary 5 Prior authorization
Prior authorization tobramycin Tobi podhaler Aminoglycoside 3 5 Alternative: tobramycin (generic Tobi)
C Q M Select Formulary Changes The Pharmacy and Therapeutics Committee made the following formulary changes effective January 1, 2017. The Select Formulary can be found in the HMSA Provider Resource Center: hmsa.com/portal/provider/index.htm.
Utilization Management Generic Name Brand Name Drug Class Current Tier New Tier Description/Notes
conjugated estrogens/ Duavee Estrogen combination 3 2 bazedoxifene ketorolac nasal spray Sprix NSAIDs 3 3 Prior authorization
Step therapy: must try metformin linagliptin/metformin Jentadueto XR Antidiabetic 3 3 HCl XR Alternatives: Janumet, Janumet XR, or Kombiglyze
C Q M Commercial QUEST Medicare Integration 10 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
PHARMACY (CONTINUED)
Specialty
Utilization Management Generic Name Brand Name Drug Class Current Tier New Tier Description/Notes
Prior authorization tobramycin Tobi podhaler Aminoglycoside 3 4 Alternative: tobramycin (generic Tobi)
C Q M QUEST Integration Formulary Changes The Pharmacy and Therapeutics Committee made the following changes to the HMSA QUEST Integration formulary effective January 1, 2017. We encourage you to talk with your patients to determine if a change to one of the alternative medications is appropriate. Patients who are currently taking a medication that will be removed from the formulary will need to switch to an alternative listed for the medication to be covered under their plan. If you believe your patient should continue taking the current medication, you can request a non-formulary exception. Please use the form at hmsa.com/portal/provider/CVS_Formulary_Exception_(BR)_Prior_Auth_122812.pdf. The HMSA QUEST Integration formulary can be found in the HMSA Provider Resource Center: hmsa.com/portal/ provider/index.htm.
Applies to Utilization Medication Strength Drug class Change/Criteria New Rx Management Only
lidocaine-prilocaine 2.5-2.5% Topical QL Quantity limit: 30 grams per 1 month No cream
100-150 mg Truvada tablet 133-200 mg Anti-infective Formulary addition No 167-250 mg
13800 unit Non-formulary Ultresa capsule 20700 unit Gastrointestinal No 23000 unit Alternatives: Creon, Viokace, Zenpep
Vistogard Pak 10 gm Antidote Formulary addition No
Specialty
Applies to Utilization Medication Strength Drug class Change/Criteria New Rx Management Only
8 mg Formulary addition Lenvima capsule Antineoplastic agent PA No 18 mg Prior authorization
Nuplazid tablet 17 mg Central nervous system PA Formulary addition No
10 mg Formulary addition Venclexta tablet 50 mg Antineoplastic agent PA No 100 mg Prior authorization
Venclexta tablet 10 & 50 Formulary addition Antineoplastic agent PA No starter pack & 100 mg Prior authorization
C Q M Commercial QUEST Medicare Integration 11 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
PLANS
C Q M Assistant Surgeon Claims QUEST Integration has amended the claim requirements for surgical assistants at teaching hospitals to match the commercial plan requirements. You no longer need to submit a non-availability certification statement indicating that a qualified resident isn’t available as long as modifier 82 is appended to the surgical procedure. Assistant claims at teaching hospitals submitted without the modifier will be denied as Surgical Assistant Not Required at Resident Hospital. Details of the assistant surgeon policy are in the Provider Resource Center at hmsa.com/portal/provider/zav_QI.04. AST.50.htm.
POLICY NEWS
C Q M Gender Identity Services HB2084 HD2 SD1 was signed into law and is effective with new health plans and plans renewing on or after January 1, 2017. The new law prohibits the denial, exclusion, or limitation of health care services or treatment to a person on the basis of a person’s actual or perceived gender identity. HMSA’s Gender Identity Services medical policy addresses coverage of treatments for gender dysphoria and describes coverage of psychotherapy, fertility counseling, genital reassignment surgery, mastectomy, preventive services, continuous hormone replacement therapy, and puberty suppression therapy. It provides detail on precertification requirements, coverage criteria, and limitations. The policy is available in the Provider Resource Center at hmsa.com/portal/provider/zav_IN.MM00_Medical_Policies_Current_INDEX.htm. For your reference, a copy of HB 2084 can be found at capitol.hawaii.gov/session2016/bills/HB2084_SD1_.pdf. This summary is intended for general informational purposes only and shouldn’t be used for legal advice. Please consult a legal professional if you need legal interpretation or guidance concerning this law.
C Q M Annual Review of Medical Policies The following policies have been reviewed and updated in the Provider E-Library at hmsa.com/prc0006; printed copies are available on request. • Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions. • Composite Tissue Allotransplantation of the Hand and Face (doesn’t apply to QUEST Integration). • Measurement of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in the Assessment of Cardiovascular Risk. • Clinical Trials — Routine Costs. • Real-Time Intra-Fraction Motion Management During Radiation Therapy. • Knee Orthoses for Osteoarthritis.
C Q M Commercial QUEST Medicare Integration 12 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
POLICY NEWS (CONTINUED)
C Q M Significant Changes for Policies Requiring 90-day Notice The following policies have undergone significant changes and go into effect January 1, 2017: • Catheter Ablation as Treatment for Atrial Fibrillation. • Ambulatory Event Monitors and Mobile Cardiac Outpatient Telemetry. • Spinal Cord Stimulation (previously titled Spinal Cord Stimulators for Pain Management). • Extracorporeal Membrane Oxygenation (ECMO).
C Q M 90-day Notice of Medical Specialty Drug Policy Changes The following policy has been updated and goes into effect January 1, 2017: • H.P. Acthar Gel. Please refer to the current medical specialty drug policies online for more information, including prior authorization requirements, at info.caremark.com/hmsapolicies.
Medical policies are in the Provider E-Library at hmsa.com/prc0004. For copies, call Provider Services at 948-6330 on Oahu or 1 (800) 790-4672 toll-free on the Neighbor Islands.
C Q M Commercial QUEST Medicare Integration 13 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
CALENDAR
C Q M Well-Being Workshops The following workshops are available to HMSA members at no cost. These informative sessions can help your patients improve their health and well-being. For more information, refer your patients to hmsa.com/well-being/workshops or have them call 1 (855) 329-5461 toll-free to register at least three days before the workshop date.
Diabetes 101 Sweet Dreams Learn about recommended tests and Find out how much sleep you need treatment options. and how to get better sleep. • 10/8, 10–11 a.m. • 10/10, 10–11 a.m. HMSA Kailua-Kona Office HMSA Center @ Pearl City • 10/11, 6–7 p.m. • 10/17, 5–6 p.m. Kapiolani Women’s Center at Artesian Plaza Kuhio Medical Center Hypertension Explained • 10/21, 10–11 a.m. High blood pressure can be a major threat HMSA Center @ Pearl City to physical health. Learn strategies to help control hypertension. • 10/22, 10–11 a.m. HMSA Center @ Hilo • 10/14, 10–11 a.m. HMSA Maui Office • 10/25, 5:30–6:30 p.m. Kaimuki Plaza, Kaimana Room • 10/15, 10–11 a.m. HMSA Center @ Pearl City • 10/27, 9:30–10:30 a.m. HMSA Center @ Honolulu RE | THINK Retrain your brain to think positive thoughts What the Heck IS Cholesterol? and improve your well-being. Find out how much sleep you need • 10/22, 10–11 a.m. and how to get better sleep. Kaimuki Plaza, Kaimana Room • 10/4, 10–11 a.m. • 10/28, 10–11 a.m. HMSA Center @ Hilo HMSA Center @ Honolulu Senior Fitness Find out how to maintain strength and mobility as you age. • 10/19, 12:30–1:30 p.m. Kalihi YMCA
C Q M Community Activities Adult Fitness at Queen’s: Learn Jazzercise, tai chi, kickboxing, yoga, and more. Times and instructors vary. The Queen’s Medical Center, Women’s Health Center Classroom. Six classes for $66. 691-7117 for details and to register. Health & Education at Queen’s: The Queen’s Medical Center, Women’s Health Center Classroom. • Genetics Class: Learn about prenatal genetic screening and tests to check the health of your baby. 691-7633. Free.
C Q M Commercial QUEST Medicare Integration 14 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
CALENDAR (CONTINUED)
• Lamaze Class: Sundays, 1–4 p.m. Get birthing techniques from a Lamaze-certified instructor in this birth- partner-focused class. $150 per couple for five sessions. Instructor: Nicia Platt. • Lymphedema/Breast Cancer Clinic: First and third Thursdays,1:30–2:30 p.m. Learn exercises to prevent lymphedema (swelling of the arms). Free. • Mammogram and Cervical Cancer Screening: Every other Friday, 8 a.m.–noon. Free for women ages 50–64, uninsured or underinsured, or low income. 691-7726. Support Groups and Educational Classes at Queen’s Cancer Center: queensmedicalcenter.org/cancer-concerns or 691-8984. Aloha Kidney Classes: Learn how to manage conditions related to chronic kidney disease (CKD). Free six-week series. To enroll or for more information, go to alohakidney.com or call 585-8404. Next series will begin: • October 1, 9–11:30 a.m. The Queen’s Medical Center, Kamehameha Auditorium. • October 1, 1–3:30 p.m. Pali Momi Medical Center, Diamond Head Conference Room. • October 3, 5–7:30 p.m. Castle Wellness Center, Weinberg Building. Blue Zones Project® Hawaii Events: Blue Zones Project is transforming Hawaii’s schools, restaurants, grocery stores, and communities. Join the movement by attending free workshops, demonstrations, and tours. hawaii.bluezonesproject.com. Big Island Ostomy Group: October 15, 11 a.m. Hilo Medical Center. Open to ostomates, pre-ostomy patients, caregivers, medical professionals, and the general public. 339-7640. Castle Wellness Center Events: Castle Medical Center Wellness Auditorium. • Eat Well for Life: October 27, 6–7:15 p.m. Global cuisine … with a vegan touch. This month, Eastern European food featuring root vegetables and whole grains; includes recipes. $10 per person; registration and prepayment are required. Call 263-5400 or visit castlemed.org. • How Not to Die: October 12, 6–7:30 p.m. Explore the role diet may play in preventing, arresting, and even reversing the leading causes of death and disability. Preregistration is required. Call 263-5400 or visit castlemed.org. • What’s New in Palliative Care: October 13, 6–7:30 p.m. Learn about the newest program in palliative and hospice care. Preregistration is required. Call 263-5400 or visit castlemed.org. COPD Support Group: October 11, 10 a.m.–noon. Pali Momi Women’s Center at Pearlridge. Get support and information on medication, breathing techniques, exercise, and more. To register, call Valerie Chang at 699-9839, email [email protected], or visit hawaiicopd.org. Diabetes Adult Support Group: October 6, 1–2:30 p.m. American Diabetes Association Office, Honolulu. This month’s topic is “Diabetes Myths and Facts.” Free. Parking validation available. 947-5979. • Hawaii Island: West Hawaii Community Health Center. Call to confirm schedule. 326-5629. • Maui: Maui Memorial Medical Center. Meets every second Wednesday, 6:30–7:30 p.m. 442-5773. Farmers Market at HMSA: Every Friday, 11 a.m.–2 p.m. HMSA Center @ Honolulu. Fresh, island-grown produce and ready-to-eat local food. For information on vendors, call HMSA at 948-6521. Frankly Speaking About Cancer: October 28, 5:30–7:30 p.m., Queen’s Medical Center, West Oahu. This free, two-hour workshop will cover the latest treatments for lung cancer. Expert panelists will also discuss side effects, side-effect management, and tools to overcome social and emotional challenges. For more details and to RSVP, call Inji Kim at 687-5377, email [email protected], or visit cancersupportcommunity.org.
Blue Zones Project® is a trademark of Blue Zones, LLC. All rights reserved.
C Q M Commercial QUEST Medicare Integration 15 w HealthPro News - Health Care Providers, Facilities, and Staff October 2016
CALENDAR (CONTINUED)
Hawaii Prostate Cancer Support Group: This free support group provides men and their families with information, materials, and support to help them make informed decisions about prostate cancer treatment. For locations and meeting times, go to hawaiiprostatecancer.org or call 486-9675. Holiday Craft Fair and Bake Sale: November 4, 8:30 a.m.–1 p.m. Kuakini Medical Center. The sale will feature unique handcrafted items and baked goods from Kuakini Health System employees and volunteers, members of Kuakini’s medical staff, and employees of a Kuakini campus physician office. Free and open to the public. Kardiac Kids Support Group: October 14, 6:30–9 p.m. Kapiolani Medical Center Cafeteria. Education, encourage- ment, and support to families with children who have congenital heart defects. Jullie Passos, 227-4558. LUNG FORCE Walk – Honolulu: November 5, 8 a.m. registration. Magic Island, Honolulu. Walk to support lung cancer research and education. For more information, call Kim Nguyen at 687-5375. Mommy & Me Hui: Every Friday, 11:15 a.m.–12:30 p.m. Castle Medical Center. Learn about breastfeeding and connect with new mothers. 263-5400. National Kidney Foundation of Hawaii Classes: Learn about nutrition for hemodialysis, weight management, and healthy eating for keiki and kupuna. To find a class, go to kidneyhi.org. Rehabilitation Hospital of the Pacific (REHAB) Support Groups: 531-3511. • Stroke Club: For stroke survivors and their caregivers. Meets at the hospital on the first Tuesday of every month, 10-11:30 a.m. • Neuro Chess Club: For brain injury and stroke survivors and their family members and caregivers. Meets at the hospital on the last Wednesday of every month, 6-7:30 p.m. Stroke Support Group: October 11, 4–5 p.m. Hilo Medical Center. A forum for stroke survivors, caregivers, family members, and friends. Amy Shipley, 932-3049 or [email protected]. Walk with a Doc on Hawaii Island: Every Sunday, 8 a.m. Liliuokalani Gardens, Hilo. Walk includes a brief warm-up/stretch and an informative talk from a community doctor or medical student. Meets rain or shine. wwadbigisland.org.
C Q M Commercial QUEST Medicare Integration